. Space Industry and Business News .




.
EPIDEMICS
To cheers, HIV drugs trial sets AIDS campaign on new course
by Staff Writers
Rome (AFP) July 18, 2011

Researchers at a world AIDS conference Monday stood up to cheer a trial proving that early use of drugs to treat HIV all but eliminates the risk of transmitting the killer virus through heterosexual intercourse.

Experts said the bold experiment marked a turning point in a disease that has claimed some 30 million lives and left 34 million people infected with HIV.

They said widening access to antiretroviral drugs would deliver a double whammy: millions of people infected by the human immunodeficiency virus (HIV) would be saved and millions of new infections would be averted.

But they stressed that the message of safe sex that has shadowed AIDS for the past three decades should not be abandoned.

And before "treatment as prevention" is launched as a strategy, it would need carefully crafted guidelines and billions of dollars in support, at a time when funding for AIDS is faltering.

"We are at an important tipping point," Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases (NIAID), told AFP.

"There is an extraordinary window of opportunity and the sooner we act on it and the more robustly we act on it, the quicker we'll achieve the goal of turning around the epidemic," he said.

"Now's the time to translate this science into action that can break the back of the epidemic," the group Medecins Sans Frontieres (Doctors Without Borders) said. "The clock is ticking."

Casting aside their traditional reserve, delegates cheered and gave a standing ovation to Myron Cohen, a professor at the University of North Carolina at Chapel Hill, who led the landmark HPTN 052 trial.

The data had been initially unveiled to the press in May on the orders of monitors, who said the results were so startling that all participants had to be advised of the outcome on ethical grounds.

Its presentation at the world's top scientific conference on AIDS, and concurrent publication in the peer-reviewed New England Journal of Medicine, now enshrines it as a benchmark to which policymakers will refer.

HPTN 052 was carried out among 1,763 couples in nine countries where one partner was infected with HIV while the other was HIV-free.

When the infected partner was given an early start on HIV drugs, this slashed the risk of transmitting the virus to the other by 96 percent -- a figure readily comparable to the effectiveness of a condom.

Alongside the HPTN presentation were two other trials, made public last week, which found a reduction of up to 73 percent in risk when the non-infected partner, as opposed to the infected partner, took the antiretrovirals.

Experts said many tasks lay ahead in transposing a trial, which takes place in carefully controlled conditions where couples are counselled and supported, into the messy reality of everyday life.

The UN's World Health Organisation (WHO) on Monday said it would delay plans to revise its guidelines on antiretrovirals to give it time to ponder the radically altered landscape.

However, the use-a-condom message will remain in place, said the WHO's Gottfried Hirnschall.

"Messaging is critical and clearly we not just talking about a single intervention, we are talking about a combination prevention," he told a press conference.

"We would never at this point want to say, let's do just one thing and say 'don't use condoms'."

Another question is funding. Around 16 billion dollars have been earmarked to fight AIDS this year, compared to needs estimated at 22 to 24 billion dollars.

"The priority right now is reaching people who really need treatment," argued Michel Kazatchkine, head of the Global Fund to Fight AIDS, Tuberculosis and Malaria.

"(...) Putting everyone on treatment is not a prospect, either from the resource point of view or from the operational point of view. Half of the people who are infected aren't even aware of their (infection) status."

The four-day conference, staged once every two years by the International AIDS Society (IAS), gathers 5,500 specialists, ranging from virologists to pharmacologists and disease trackers. It ends on Wednesday in Rome.




Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola

.
Get Our Free Newsletters Via Email
...
Buy Advertising Editorial Enquiries






. Comment on this article via your Facebook, Yahoo, AOL, Hotmail login.

Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle



EPIDEMICS
HIV prevention: Drugs even more effective than thought
Rome (AFP) July 18, 2011
Using HIV treatment drugs to reduce the risk of spreading the AIDS virus may be even more effective than thought, according to new analysis from a landmark trial presented here on Monday. The four-day meeting in Rome under the International AIDS Society was given the first full peer-reviewed data from a trial whose preliminary results were unveiled to media in May to astonishment and acclaim ... read more


EPIDEMICS
Earnings-outlook spry at 100-year-old IBM

25 Tesla, world-record 'split magnet' makes its debut

U.S. watches helium stockpile dwindle

Kakao is sweet for S. Korean smartphone users

EPIDEMICS
Celebrating 10 years of Artemis

Raytheon BBN Technologies Awarded $2.4 Million to Advance Satellite Communications

Raytheon Wins Competitive Long Term Evolution Broadband Communications Network Contract

Battlefield Airborne Communications Node System Completes 2,000 Tactical Missions

EPIDEMICS
Countdown commenced for PSLV-C17/GSAT-12 Mission

SpaceX Names Mark Bitterman Senior Vice President of Government Affairs

Globalstar Satellites Now Scheduled for Launch on July 13th

Arianespace uses Soyuz to loft six Globalstars to orbit from Baikonur

EPIDEMICS
Boeing: 2nd Boeing GPS IIF Satellite Ready for Launch from Cape Canaveral

Apple makes first S. Korea payout over tracking

A new algorithm could help prevent midair collisions

AI Solutions to Assist Air Force with GPS Satellite Positioning Data and Analyzing GPS Anomalies

EPIDEMICS
Flight Options buys Embraer executive jets

Aerospace plant opened in Romania

DLR examines the benefits of sectorless airspace

Boeing Values India Market for 1320 New Airplanes at 150 Billion Dollars

EPIDEMICS
Soft Memory Device Opens Door To New Biocompatible Electronics

Expert help from a distance

NIST prototype optics table on a chip places microwave photon in 2 colors at once

Light propagation controlled in photonic chips marks major breakthrough in telecommunications field

EPIDEMICS
Underwater Antarctic Volcanoes

Lockheed Martin and Esri Sign Partnership Towards On-Demand Geospatial Apps and Services

Astrium to build Sentinel-4 atmospheric sensors

Dr VS Hegde Appointed as Chairman and Managing Director of Antrix Corporation Limited

EPIDEMICS
Mideast lung disease up with chemical wars

Hungary presents new homes to toxic spill families

Baghdad chlorine gas leak causes panic

Mongolia herder on mission to tackle mining firms


Memory Foam Mattress Review
Newsletters :: SpaceDaily Express :: SpaceWar Express :: TerraDaily Express :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News
.

The content herein, unless otherwise known to be public domain, are Copyright 1995-2011 - Space Media Network. AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement